Health Care & Life Sciences » Pharmaceuticals | Adcock Ingram Holdings Ltd.

Adcock Ingram Holdings Ltd. | Income Statement

Fiscal year is July-June. All values ZAR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
4,820
5,159
5,546
5,936
6,540
Cost of Goods Sold (COGS) incl. D&A
3,367
3,295
3,525
3,746
3,974
Gross Income
1,453
1,864
2,020
2,190
2,566
SG&A Expense
1,474
1,356
1,456
1,494
1,734
EBIT
195
-
564
684
832
Unusual Expense
821
21
13
6
13
Non Operating Income/Expense
277
23
13
6
4
Interest Expense
129
96
77
38
26
Pretax Income
1,397
426
491
661
816
Income Tax
72
142
171
205
251
Equity in Affiliates
43
66
59
64
79
Consolidated Net Income
1,283
350
379
520
644
Net Income
1,287
349
369
514
638
Net Income After Extraordinaries
1,287
500
569
474
638
Net Income Available to Common
1,287
198
169
519
638
EPS (Basic)
7.63
1.17
1.01
3.33
3.84
Basic Shares Outstanding
169
169
166
166
166
EPS (Diluted)
7.63
1.17
1.01
3.33
3.84
Diluted Shares Outstanding
169
169
166
166
166
EBITDA
14
646
711
834
-
Other Operating Expense
175
2
-
13
-
Non-Operating Interest Income
25
9
3
16
18
Minority Interest Expense
4
1
10
6
6

About Adcock Ingram Holdings

View Profile
Address
1 New Road
Midrand GT 1682
South Africa
Employees -
Website http://www.adcock.co.za
Updated 07/08/2019
Adcock Ingram Holdings Ltd. is a pharmaceutical company. It operates through the following segments: Over the Counter, Consumer, Prescription and Hospital. The Over the Counter segment focuses primarily on brands sold predominantly in the pharmacy market, where the pharmacist plays a role in the product choice.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.